Expert neurologists share their goals and patient considerations for preventive migraine therapy.
Andrew C. Charles, MD
Advertisement
Articles by Andrew C. Charles, MD
Andrew C. Charles, MD, provides a historical perspective on the agents traditionally used for preventive migraine therapy.
Advertisement
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Reverses Course on AMT-130, Citing Insufficient External Data for Submission
2
Understanding the Barriers of Health Insurance in Stroke Rehabilitation Care
3
FDA Approves New Intrathecal Administration Route for Spinal Muscular Atrophy Gene Therapy
4
GLP-1 Semaglutide Fails to Outperform Placebo in Phase 3 EVOKE Trial of Alzheimer Disease
5
